VILELLA, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 7.957
AS - Asia 3.805
EU - Europa 3.304
SA - Sud America 565
Continente sconosciuto - Info sul continente non disponibili 145
AF - Africa 110
OC - Oceania 10
Totale 15.896
Nazione #
US - Stati Uniti d'America 7.649
IT - Italia 1.138
SG - Singapore 1.117
CN - Cina 1.007
GB - Regno Unito 946
BR - Brasile 436
HK - Hong Kong 428
VN - Vietnam 416
DE - Germania 217
SE - Svezia 209
BD - Bangladesh 203
FI - Finlandia 144
RU - Federazione Russa 144
CA - Canada 143
KR - Corea 140
FR - Francia 101
TR - Turchia 96
IN - India 91
UA - Ucraina 86
ID - Indonesia 59
MX - Messico 56
NL - Olanda 49
AR - Argentina 47
BG - Bulgaria 42
ZA - Sudafrica 39
ES - Italia 36
JP - Giappone 36
LT - Lituania 31
IE - Irlanda 27
IQ - Iraq 27
EC - Ecuador 23
PL - Polonia 22
BE - Belgio 21
PK - Pakistan 21
CL - Cile 20
IL - Israele 20
CO - Colombia 18
AE - Emirati Arabi Uniti 16
AT - Austria 16
UZ - Uzbekistan 15
MY - Malesia 14
CR - Costa Rica 13
HN - Honduras 12
RO - Romania 12
TT - Trinidad e Tobago 12
IR - Iran 11
PH - Filippine 11
TN - Tunisia 11
JM - Giamaica 10
JO - Giordania 10
SA - Arabia Saudita 10
AU - Australia 9
CZ - Repubblica Ceca 9
DZ - Algeria 9
NO - Norvegia 9
EG - Egitto 8
EU - Europa 8
MA - Marocco 8
PR - Porto Rico 8
SC - Seychelles 8
TH - Thailandia 8
VE - Venezuela 8
CU - Cuba 7
CW - ???statistics.table.value.countryCode.CW??? 7
KE - Kenya 7
KZ - Kazakistan 7
NI - Nicaragua 7
SV - El Salvador 7
AN - Antille olandesi 6
CH - Svizzera 6
DO - Repubblica Dominicana 6
EE - Estonia 6
LB - Libano 6
NP - Nepal 6
PY - Paraguay 6
AL - Albania 5
AZ - Azerbaigian 5
GP - Guadalupe 5
PA - Panama 5
PT - Portogallo 5
TW - Taiwan 5
AO - Angola 4
BO - Bolivia 4
GR - Grecia 4
GT - Guatemala 4
OM - Oman 4
SN - Senegal 4
BH - Bahrain 3
CI - Costa d'Avorio 3
ET - Etiopia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AG - Antigua e Barbuda 2
AM - Armenia 2
BB - Barbados 2
BY - Bielorussia 2
BZ - Belize 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
Totale 15.739
Città #
Ashburn 1.039
Southend 679
Santa Clara 661
Singapore 608
San Jose 562
Fairfield 471
Hong Kong 421
Chandler 384
Hefei 371
Council Bluffs 303
Woodbridge 294
Houston 219
Seattle 217
Modena 212
Beijing 202
Chicago 190
Ann Arbor 179
Wilmington 174
Los Angeles 168
Cambridge 152
Dearborn 141
Ho Chi Minh City 139
Nyköping 135
London 131
Jacksonville 128
Seoul 128
New York 113
Helsinki 105
Hanoi 94
The Dalles 89
Milan 75
Bologna 62
Como 55
Munich 51
Rome 51
Buffalo 47
Izmir 46
São Paulo 45
Lauterbourg 43
Princeton 43
Salt Lake City 42
Dallas 41
Jakarta 40
Sofia 40
San Diego 38
Moscow 35
Parma 34
Eugene 33
Columbus 32
Orem 32
Toronto 30
Reggio Emilia 29
Chennai 28
Tokyo 27
Frankfurt am Main 26
Phoenix 26
Redwood City 26
Brooklyn 24
Atlanta 22
Kocaeli 22
Mexico City 22
Montreal 22
Shanghai 22
Boardman 21
Da Nang 21
Guangzhou 21
Boston 19
Johannesburg 19
Naples 19
Warsaw 18
Dublin 17
Elk Grove Village 17
Fremont 17
North Bergen 17
Tampa 17
Haiphong 16
Stockholm 16
Washington 16
Correggio 15
Madison 15
Amsterdam 14
Brasília 14
Brussels 14
Poplar 14
Quito 14
Bremen 13
Lancaster 13
Manchester 13
Tashkent 13
Willemstad 13
Redondo Beach 12
Sterling 12
Tulare 12
Zhengzhou 12
Baghdad 11
Nuremberg 11
Ottawa 11
Saint Augustine 11
Vancouver 11
Denver 10
Totale 10.469
Nome #
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 462
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 447
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 421
Activity and circadian rhythm influence synaptic Shank3 protein levels in mice 421
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 404
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 388
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 387
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response 386
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 385
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 377
Heterosynaptic GABAergic plasticity bidirectionally driven by the activity of pre- and postsynaptic NMDA receptors 360
Distribution and relative abundance of S100 proteins in the brain of the APP23 Alzheimer’s disease model mice 359
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 353
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 351
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 350
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 350
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 350
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 344
In vivo study of the role of a6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin 341
Astrocyte-targeted production of IL-10 induces changes in microglial reactivity and reduces motor neuron death after facial nerve axotomy 330
DAT atypical inhibitors as novel antipsychotic drugs 317
A regional and cellular analysis of the early intracellular and extracellular accumulation of Aβ in the brain of 5XFAD mice 312
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 308
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 303
Neuronal and extraneuronal nicotinic acetylcholine receptors 301
Nanoparticles and the BBB crossing: in vivo and in vitro upcomings 299
Bioresorbable Nanostructured Chemical Sensor for Monitoring of pH Level In Vivo 293
Nano-Neuroscience: Targeted nanoparticles For CNS drug delivery 292
Brain targeting by engineered nanoparticles 289
Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice 287
Nanomedicine in Neuroscience: the potential of targeted nanoparticles in crossing the Blood-Brain Barrier 278
Nanotechnology and Central Nervous System Drug Delivery 277
Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocyte-targeted production of interleukin-10 267
Rab5-dependent cell-specific uptake and distribution of engineered nanoparticles for CNS targeted drug delivery in vivo 258
PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer’s Disease 255
Female mice exhibit similar long-term plasticity and microglial properties between the dorsal and ventral hippocampal poles 237
Implantable and Bioresorbable Nanostructured Fluorescence Sensor for In vivo pH Monitoring 228
Nanomedicine in Neuroscience: The potential of targeted nanoparticles in neurodegenerative disorders 226
S100B dysregulation during brain development affects synaptic SHANK protein networks via alteration of zinc homeostasis 221
Dorsal and ventral striatal neuronal subpopulations differentially disrupt male mouse copulatory behavior 217
Targeting Metal Homeostasis as a Therapeutic Strategy for Alzheimer’s Disease 204
Nanomedicine in neurodegenerative disorders: Understanding the journey 204
Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease 204
MicroRNA-218 instructs proper assembly of hippocampal networks 199
Hydroxypropyl-β-Cyclodextrin Depletes Membrane Cholesterol and Inhibits SARS-CoV-2 Entry into HEK293T-ACEhi Cells 182
Evidence for a protective effect of the loss of α4-containing nicotinic acetylcholine receptors on Aβ-related neuropathology in Tg2576 mice 179
Two minimally invasive strategies to implant guide cannulas for multiple injections in deep brain areas 166
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 164
Targeted metabolomics for the analysis of p-Cresol in mouse brain by HPLC-ESI-MS/MS 163
Targeted metabolomics for the analysis of p-cresol in mouse brain by HPLC-ESI-MS/MS 161
The Role of Trace Metals in Alzheimer’s Disease 160
Long-term behavioral and histological profile following CA3 ventral lesion 159
Targeted Metabolomics for the Analysis of p-Cresol in Mouse Brain: Impact of Biological Sex and Strain 157
Placebo effect between evidence and myths: How to distinguish true from fake news 157
Una nuova strategia per ingannare la barriera emato-encefalica: studio in vivo di captazione, distribuzione e trasporto di nanoparticelle nel cervello. 124
Reference gene variability across age and sex in 5XFAD mice highlights normalization challenges in Alzheimer’s models 72
Thermally Degradable Biocompatible Hydrogel as Transient Encapsulation Coating for Implantable Sensors 60
In vivo and in situ monitoring of doxorubicin pharmacokinetics with an implantable bioresorbable optical sensor. 50
Multiparametric Bioresorbable Sensor for Doxorubicin Detection via Molecularly Imprinted Synthetic Receptors 47
DevelopmentofaBiodegradableGreenEmitterChitosan-Based OLEDfor ImplantableBiomedicalDevices 42
Alginate attenuates reactive microglia in vivo 11
Totale 15.896
Categoria #
all - tutte 62.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022636 0 0 0 0 28 37 33 67 101 78 170 122
2022/2023959 104 128 93 90 104 106 13 103 110 15 50 43
2023/2024696 29 33 59 77 149 51 64 78 16 15 48 77
2024/20252.626 95 26 56 160 434 368 222 162 212 194 353 344
2025/20265.562 394 202 382 672 958 322 562 256 533 522 493 266
2026/20271.733 209 305 489 577 153 0 0 0 0 0 0 0
Totale 15.896